Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest
Open Access
- 1 November 2017
- journal article
- Published by Elsevier BV in Clinical Biochemistry
- Vol. 50 (16-17), 903-910
- https://doi.org/10.1016/j.clinbiochem.2017.06.001
Abstract
No abstract availableKeywords
Funding Information
- pfizer Spain (WS1541122)
This publication has 35 references indexed in Scilit:
- Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritisNature Reviews Rheumatology, 2014
- When and where does inflammation begin in rheumatoid arthritis?Current Opinion in Rheumatology, 2014
- Structural Changes and Antibody Enrichment in the Lungs Are Early Features of Anti–Citrullinated Protein Antibody–Positive Rheumatoid ArthritisArthritis & Rheumatology, 2013
- Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritisAutoimmunity Reviews, 2012
- Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?Rheumatology, 2010
- Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patientsArthritis & Rheumatism, 2009
- Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapyArthritis Research & Therapy, 2008
- Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluidsAnnals Of The Rheumatic Diseases, 2006
- Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentinArthritis Research & Therapy, 2004
- Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritisArthritis Research & Therapy, 2004